Semaglutide
GLP-1 receptor agonist studied in type 2 diabetes and obesity. One of the most investigated peptides of the past decade.
Approved
View profile Library
Peptide library
Technical profiles with physicochemical data, mechanism and evidence level.
Tirzepatide
Dual GIP and GLP-1 receptor agonist. The first “twincretin” to reach the market.
Approved
View profile Retatrutide
Triple GIP, GLP-1 and glucagon receptor agonist, currently in phase 3 clinical trials.
Phase 3
View profile BPC-157
Pentadecapeptide derived from a gastric juice protein. Widely studied in animal models; human data are scarce.
Preclinical
View profile GHK-Cu
Naturally occurring tripeptide in human plasma with high affinity for copper. Widely used in dermatological and cosmetic research.
Preclinical
View profile Ipamorelin
Selective growth hormone secretagogue and ghrelin receptor agonist. Reached phase 2 clinical trials.
Early clinical
View profile Thymosin Alpha-1
Thymus-derived immunomodulatory peptide. Approved in several countries as thymalfasin, but not registered in Brazil.
Approved
View profile Epitalon
Synthetic tetrapeptide inspired by pineal gland extracts. Researched in ageing biology, with limited evidence.
Preclinical
View profile